The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online August 12, 2009
The Journal of Immunology, 2009, 183, 3317 -3323
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0901504

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0901504v1
183/5/3317    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Smith, P. M.
Right arrow Articles by Stadecker, M. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, P. M.
Right arrow Articles by Stadecker, M. J.

Genetic Control of Severe Egg-Induced Immunopathology and IL-17 Production in Murine Schistosomiasis1

Patrick M. Smith{dagger}, Mara G. Shainheit{dagger}, Lindsey E. Bazzone*, Laura I. Rutitzky*, Alexander Poltorak*,{dagger} and Miguel J. Stadecker2,*,{dagger}

* Department of Pathology and {dagger} Immunology Program, Sackler School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA 02111

Infection with the trematode parasite Schistosoma mansoni results in a distinct heterogeneity of disease severity, both in humans and in an experimental mouse model. Severe disease is characterized by pronounced hepatic egg-induced granulomatous inflammation in a proinflammatory cytokine environment, whereas mild disease corresponds with reduced hepatic inflammation in a Th2 skewed cytokine environment. This marked heterogeneity indicates that genetic differences play a significant role in disease development, yet little is known about the genetic basis of dissimilar immunopathology. To investigate the role of genetic susceptibility in murine schistosomiasis, quantitative trait loci analysis was performed on F2 progeny derived from SJL/J and C57BL/6 mice, which develop severe and mild pathology, respectively. In this study, we show that severe liver pathology in F2 mice 7 wk after infection significantly correlated with an increase in the production of the proinflammatory cytokines IL-17, IFN-{gamma}, and TNF-{alpha} by schistosome egg Ag-stimulated mesenteric lymph node cells. Quantitative trait loci analysis identified several genetic intervals controlling immunopathology as well as IL-17 and IFN-{gamma} production. Egg granuloma size exhibited significant linkage to two loci, D4Mit203 and D17Mit82, both of which were inherited in a BL/6 dominant manner. Furthermore, a significant reduction of hepatic granulomatous inflammation and IL-17 production in interval-specific congenic mice demonstrated that the two identified genetic loci have a decisive effect on the development of immunopathology in murine schistosomiasis.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Public Health Service Grant R01-18919.

2 Address correspondence and reprint requests to Dr. Miguel J. Stadecker, Department of Pathology, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111. E-mail address: miguel.stadecker{at}tufts.edu

3 Abbreviations used in this paper: QTL, quantitative trait loci; CI, confidence interval; CIA, collagen induced arthritis; EAE, experimental autoimmune encephalomyelitis; LOD, logarithm of the odds; MLN, mesenteric lymph node; SEA, Schistosome egg antigens; SLE, systemic lupus erythematosus.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.